Codiak BioSciences, Inc. Increase (Decrease) in Contract with Customer, Liability
Codiak BioSciences, Inc. reported Increase (Decrease) in Contract with Customer, Liability of -$24.97 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2022-11-03
- Codiak BioSciences, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2022-09-30 was $1.05M.
- Codiak BioSciences, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2022-06-30 was -$13.31M, a 2710.20% decline year-over-year.
- Codiak BioSciences, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2022-03-31 was -$12.70M.
- Codiak BioSciences, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2021-12-31 was -$7.09M.
- Codiak BioSciences, Inc. increase (decrease) in contract with customer, liability for fiscal 2021 was -$19.05M, a 368.85% decline from fiscal 2020.
- Codiak BioSciences, Inc. increase (decrease) in contract with customer, liability for fiscal 2020 was $7.08M, a 87.26% decline from fiscal 2019.
- Codiak BioSciences, Inc. increase (decrease) in contract with customer, liability for fiscal 2019 was $55.61M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2022-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$12.27M derived: sum of 2 quarters · filed 2022-11-03 | -$24.97M 10-Q · filed 2022-11-03 | -$32.06M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | -$13.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$26.02M 10-Q · filed 2022-08-04 | -$33.11M derived: sum of 3 quarters · filed 2022-08-04 | -$33.23M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | -$12.70M 10-Q · filed 2022-05-05 | -$19.80M derived: sum of 2 quarters · filed 2022-05-05 | -$19.92M derived: sum of 3 quarters · filed 2022-11-03 | -$19.41M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | -$7.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$7.21M derived: sum of 2 quarters · filed 2022-11-03 | -$6.70M derived: sum of 3 quarters · filed 2022-11-03 | -$19.05M 10-K · filed 2022-03-10 |
| 2021-09-30 | -$118.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $392.00K derived: sum of 2 quarters · filed 2022-11-03 | -$11.95M 10-Q · filed 2022-11-03 | -$13.59M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $510.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$11.84M 10-Q · filed 2022-08-04 | -$13.47M derived: sum of 3 quarters · filed 2022-08-04 | -$14.43M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$12.35M 10-Q · filed 2022-05-05 | -$13.98M derived: sum of 2 quarters · filed 2022-05-05 | -$14.94M derived: sum of 3 quarters · filed 2022-05-05 | -$5.13M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$2.59M derived: sum of 2 quarters · filed 2022-03-10 | $7.22M derived: sum of 3 quarters · filed 2022-03-10 | $7.08M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$954.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $8.86M derived: sum of 2 quarters · filed 2021-11-04 | $8.72M 10-Q · filed 2021-11-04 | $8.57M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $9.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $9.68M 10-Q · filed 2021-08-05 | $9.53M derived: sum of 3 quarters · filed 2021-08-05 | |
| 2020-03-31 | -$134.00K 10-Q · filed 2021-05-06 | -$284.00K derived: sum of 2 quarters · filed 2021-05-06 | ||
| 2019-12-31 | -$150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $55.61M 10-K · filed 2021-03-17 | ||
| 2019-09-30 | $55.76M 10-Q · filed 2020-11-19 |